申请人:——
公开号:US20020143003A1
公开(公告)日:2002-10-03
The present invention relates to compounds of the formula
1
wherein R
1
through R
4
, X, Y, m and n are defined as in the specification. Such compounds are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.
本发明涉及公式1的化合物,其中R1至R4、X、Y、m和n的定义如规范中所述。这些化合物有用,能够表现出作为血清素、去甲肾上腺素和多巴胺再摄取抑制剂的活性,以及其药学上可接受的盐,并且它们在中枢神经系统和其他疾病的治疗中使用。